Avanir Pharmaceuticals, Inc. announced the initiation of production of The PBA Film Project (working title), the first-ever documentary to provide an intimate look at real people living with a little-known neurologic condition called PseudoBulbar Affect (PBA). The award-winning filmmaker team of The PBA Film Project includes co-directors Doug Blush and Lisa Klein (Of Two Minds) and producer Julian Cautherley (The Crash Reel).
Nearly two million Americans with brain injuries or certain neurologic conditions such as Alzheimer's disease, stroke or multiple sclerosis (MS) are estimated to suffer from symptoms of PBA, marked by frequent and uncontrollable outbursts of crying or laughing. Despite the high prevalence of PBA, PBA diagnosis and awareness that it's a treatable condition is low.
"As filmmakers, we've always been drawn to human interest stories that need a microphone, whether to help raise awareness of an important issue or to inspire people to join a cause," said Doug Blush and Lisa Klein. "We believe that audiences will relate to the real people portrayed in this film as they struggle, triumph and live life to its fullest despite the obstacles of PBA and their underlying neurologic conditions."
The PBA Film Project profiles six patients living with PBA and the following neurologic conditions: stroke, traumatic brain injury (TBI), MS and frontotemporal dementia (FTD), as well as their friends, families and caregivers. The documentary is in production across the country with filming in Virginia Beach, VA; Joplin, MO; Austin, TX; Banning, CA; Tamaqua, PA and Canton, OH.
"It's inspiring to see how these patients persevere in life despite a condition that triggers unpredictable laughing or crying outbursts that can be inappropriate to the situation they are in or be more intense than the situation calls for," said Julian Cautherley. "While their neurological conditions and backgrounds are diverse, their commonality of living with PBA unites them all. I think this is something the audiences will genuinely rally behind."
Production for The PBA Film Project commenced in August 2014 and will be released to select audiences in 2015. A visually powerful experience, The PBA Film Project promises to engage and entertain, with moments of both sadness and humor.
"Avanir Pharmaceuticals is excited to be a part of a project that will shine a spotlight on PBA and the vast community it impacts," said Rohan Palekar, chief commercial officer of Avanir. "Our goal with The PBA Film Project is to create greater awareness of PBA, let patients know they are not alone and inspire them to seek help."